cropper
update
Main Street Financial News
update
  • Home
  • Categories
    • Finance
    • Trends
    • Insights
    • Literacy
    • Investment
    • Strategies
    • Tips
    • Economics
    • Markets
    • Analysis
    • Business Formation
    • Global Business Trends
    • Market Data and Financial News
    • Business Funding Updates
    • Investor Education
    • Business Finance Insights
March 06.2026
3 Minutes Read

Why Keeping a Credit Card Open for 10+ Years Benefits Your Score

Benefits of Keeping a Credit Card Open for Long Term depicted by a woman using a phone.

Understanding the Long-Term Benefits of Keeping a Credit Card

When contemplating your credit card strategy, it might be tempting to close old accounts that no longer feel relevant. However, before making any decisions, it's important to consider the many reasons why maintaining a credit card for over ten years can benefit your financial health. Here are four compelling reasons to keep that old credit card active.

1. Boosting Your Credit Score

One of the biggest components of your credit score is the length of your credit history, making up 15% of your FICO® Score. Having a credit card open for longer means you’re strengthening your credit profile. According to industry experts, if you have a longer account age, it positively influences your creditworthiness in lenders’ eyes. Closing an old card can lower your average account age and increase your credit utilization ratio, which could have a detrimental effect on your overall credit assessment.

2. Zero Cost, High Reward

If your card doesn’t come with an annual fee, keeping it open is virtually cost-free. You can maintain your credit score simply by making minimal purchases regularly without the risk of incurring high fees. Sometimes, just a small transaction every few months will suffice. This minimal activity can ensure your card remains active while allowing you to capitalize on the benefits over the years.

3. Increased Borrowing Power for Future Needs

Life is unpredictable, and having an old credit card can serve as a financial safety net. As your income and expenses fluctuate over time, your old credit card can provide access to funds without needing to go through the hassle of applying for new credit. Retaining this line of credit equips you with the financial flexibility to manage emergencies or make significant purchases.

4. Preserving Rewards and Strengthening Relationships with Your Issuer

Closing a card doesn’t just mean saying goodbye to the card itself. It may also mean losing any accumulated rewards, such as points or cashback incentives. Moreover, banking institutions value lasting relationships with their customers. Long-term customers may receive better offers, loyalty rewards, or consideration for higher credit limits. A history with your issuer can provide leverage during customer service interactions, improving your chances of receiving retention offers or requests.

When Should You Consider Closing a Credit Card?

Although there are plenty of good reasons to keep a card open, there may be times when closing an account makes sense. If your financial situation has changed, and the card no longer fits your lifestyle—such as if it charges high fees for benefits you don't utilize—it might be worth exploring downgrade options with the issuer or finally taking the plunge to close the account. Even in this scenario, consider paying down other balances first to minimize the impacts on your credit utilization ratio.

Analyzing the Changing Landscape of Credit Cards

As the financial landscape continues to evolve with new offerings and features, it’s wise to evaluate your credit card strategy annually. You may discover better rewards or features that align with your current spending habits provided by new cards on the market, surpassing value in your older accounts. Your financial goals and spending needs may shift, prompting the need for a re-assessment.

Conclusion: Make Informed Decisions for Your Financial Future

Understanding the nuances behind keeping old credit cards can help you build a stronger financial future. For those who have existing cards that have served them well, keeping them open may outweigh any short-term inconveniences. Staying informed about credit management, including how to effectively use credit cards, opens doors to financial stability and growth.

Investment

2 Views

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
05.09.2026

Is The Trade Desk Stock a Buy? Evaluating Current Investments

Update The Trade Desk: A Stock with Mixed SignalsThe Trade Desk (TTD) has been a prominent player in the digital advertising industry, yet its recent performance raises questions about whether its stock is a buy or if the recent decline is justifiable. Following a significant year-to-date drop of over 40%, analysts are hesitant to make definitive judgments, especially amid a challenging macroeconomic backdrop.Understanding Recent Performance TrendsIn the first quarter of 2026, The Trade Desk reported a revenue of $689 million, reflecting a modest increase of 12% year-over-year. However, this growth comes after a more robust 25% in the same quarter of 2025. Despite maintaining a strong customer retention rate of over 95% and generating substantial free cash flow of $276 million, the company’s decline in profitability concerns investors. The non-GAAP earnings per share fell from $0.33 to $0.28, showcasing a troubling trend that potential investors need to consider.Macroeconomic Challenges Impacting GrowthCEO Jeff Green highlighted the complex macroeconomic environment during the company’s earnings call, referencing geopolitical tensions and global economic pressures as significant hurdles. As brands adapt to these challenges, The Trade Desk’s guidance for the second quarter suggests revenue growth may slow to just 8%, raising alarms about the sustainability of its business model and growth projections. The risk of stagnant economic conditions could delay any resurgence in revenue growth and investor confidence.The Valuation Debate IntensifiesInvestors are currently faced with evaluating The Trade Desk’s valuation. Its forward price-to-earnings ratio has dropped to 19, down from its peak, but the substantial decline in growth rates complicates matters. As potential buyers reassess the balance between price and performance, the stock may not seem attractive until clear signs of growth re-emerge. Some experts argue that funds might be better allocated to companies with consistent growth prospects instead of navigating the uncertain waters that The Trade Desk currently occupies.What Does This Mean for Investors?For those contemplating their investment strategies, it’s essential to recognize the importance of asset allocation and capital preservation in volatile markets. While The Trade Desk represents an intriguing opportunity to play the shift toward open internet advertising, the risk-reward balance has become skewed. Investors keen on long-term growth should watch closely for indicators of market recovery and improvements in The Trade Desk’s operational performance.Final Thoughts: To Buy or Not to Buy?Whether The Trade Desk is worth investing in now depends heavily on individual investment philosophies. If you prefer a conservative approach that focuses on businesses demonstrating stable growth trajectories, it may be prudent to hold off on purchasing TTD stock at this juncture. Conversely, adventurous investors might view the current downturn as an opportunity if they believe that macroeconomic conditions are set to improve. So, does the current situation offer a value play, or is it still too risky? Only time will tell.

05.07.2026

ZipRecruiter (ZIP) Q1 2026 Earnings Reveal Challenges Ahead for Investors

Update Understanding ZipRecruiter's Q1 2026 Earnings Report ZipRecruiter (ZIP) announced its earnings for Q1 2026, revealing a mixed performance amid a challenging hiring environment. With revenue hitting $107.5 million, ZipRecruiter experienced a 2% decrease year-over-year and a 4% decline from the previous quarter. A combination of muted hiring demand and post-holiday seasonality was cited as key factors affecting these results. While the company's net loss stands at $4.7 million, adjusted EBITDA at $9.7 million shows resilience, indicating a 9% margin that aligns with the upper limit of management's guidance. AI Innovations Driving Engagement One of the standout initiatives in ZipRecruiter's strategy is the deployment of its new AI search and matching engine. This innovation has led to a notable 37% increase in relevant job applications for job seekers who utilized the AI-powered features. Additionally, the "Be Seen First" product has garnered interest, with over 50% of paid employers receiving responses through this feature, enhancing engagement significantly. Candidates using "Be Seen First" were almost twice as likely to get messages from employers than those employing traditional application methods, clearly positioning ZipRecruiter as a leader in leveraging AI to strengthen user interaction within its marketplace. Market Trends and Future Predictions The current hiring landscape, described by ZipRecruiter as "sluggish", is reflected in a reduction in job openings, which have dropped by 3% year-over-year. Despite this, ZipRecruiter remains hopeful that its investments in technology will yield positive returns. For Q2 2026, the company projects revenue guidance of $112 million, signaling a cautious optimism for flat year-over-year growth and a slight sequential uptick. Furthermore, management anticipates an expansion in adjusted EBITDA margins by five percentage points over the full year, which could enhance profitability in upcoming quarters if market conditions improve. Key Risks Affecting Growth Despite the company's focus on innovation, several risks loom large over ZipRecruiter's growth prospects. The ongoing decline in the quits rate and hiring activity heightens pressure on revenue generation. Management noted that this muted hiring trend may persist throughout 2026, further complicating efforts to scale operations and increase market share. As the company navigates these challenges, the impact of economic factors, such as potential shifts in U.S. trade policies and inflation, will be critical to monitor. Implications for Investors For investors, ZipRecruiter's fiscal outlook highlights both opportunities and challenges. The company's recent product innovations underscore its commitment to maintaining competitive advantages in a tightening job market. However, with net losses reported and growth projections tempered, caution is advised. Investors need to consider how effectively ZipRecruiter can convert its technological advancements into sustainable revenue, particularly in light of external economic pressures. As ZipRecruiter positions itself for future success by harnessing cutting-edge technologies like AI, understanding these dynamics is crucial for any potential investment strategy. Staying informed on market trends, company innovations, and the broader economic landscape will empower investors to make educated decisions.

05.06.2026

Which Dividend King Is the Safer Investment: AbbVie or Johnson & Johnson?

Update Choosing Between AbbVie and Johnson & Johnson: A Dividend King Dilemma When it comes to stable investments in the pharmaceutical sector, both AbbVie and Johnson & Johnson (J&J) stand tall as industry giants known for their longstanding commitment to providing returns to shareholders. As Dividend Kings, they have maintained annual dividend increases for more than 50 consecutive years. Investors seeking reliable income streams often find themselves grappling with the question: which of these two stocks is the safer bet right now? Let's explore their unique strengths and growth potentials to help investors decide. Unpacking Johnson & Johnson's Diversification Superiority Johnson & Johnson shines with its impressive diversification across pharmaceuticals and medical devices. The company operates through various sectors, including oncology and neuroscience, pioneering treatments that are crucial for patient care. Notably, J&J has leveraged this expansive portfolio to maintain healthy revenue streams, even navigating challenges like patent cliffs effectively. In 2026, J&J projects its sales to reach a remarkable $100 billion, thanks to strong ledgers from products like Stelara, despite its patent expiration. This foresight toward securing diversified revenues has fortified its status as an investment choice for those cautious of market volatility. The company's AAA credit rating from S&P Global underscores its robust financial health, making it a generally safer option for conservative investors. AbbVie's Growth Engines: Skyrizi and Rinvoq In contrast, AbbVie, while less diversified than J&J, boasts two significant growth drivers that have left an indelible mark on the market: Skyrizi and Rinvoq, each gaining substantial traction in the immunology space. Together, they helped AbbVie achieve an impressive revenue surge of 12.4% year-over-year in the first quarter of 2025, contrary to the common critique of its reliance on legacy treatments. AbbVie has effectively transitioned from the shadow of Humira, its blockbuster drug that once dominated its sales. Now, with its robust product pipeline, including promising treatments such as a weight-loss drug shown to excel in trials, AbbVie stands poised for exciting growth opportunities. However, the sustainability of this growth remains a focal point for investors as the company maneuvers through the challenges posed by biosimilars entering the market. Market Predictions: What Lies Ahead? Both AbbVie and Johnson & Johnson are expected to see continued growth, albeit through different pathways. J&J's strategy emphasizes maintaining a stable growth model through its diversified business, which can buffer against market turmoil. In comparison, AbbVie could present a higher reward if its primary growth drivers continue to succeed and expand their market footprint. According to projections, J&J anticipates a sales growth of about 6.5% for 2026, while AbbVie is aiming for a robust 9.4% growth as it continues to invest heavily in research and development. With AbbVie aiming for major revenue contributions from Skyrizi and Rinvoq, the potential for outpacing J&J is palpable if their market positioning remains resilient. Evaluating Safety in Times of Uncertainty For risk-averse investors, the choice between Johnson & Johnson and AbbVie may swiftly tilt in favor of J&J, given its longstanding reputation for stability and its extensive resources to manage ongoing legal and market issues. Yet, it’s important to acknowledge that AbbVie’s focused growth strategy could be seen as a more fertile ground for innovative breakthroughs, especially in an evolving healthcare market. As we navigate through uncertainties impacting the pharmaceutical landscape, both stocks present distinct advantages. While J&J offers robust safety and a steady income through dividends, AbbVie tempts investors with promising growth narratives fuelled by successful product launches. As an investor, understanding both risks and opportunities is vital for making informed decisions that align with one’s long-term financial goals. Making the Investment Decision: An Actionable Insight Ultimately, choosing between AbbVie and Johnson & Johnson boils down to individual risk tolerance and investment strategies. More conservative investors may find solace in the reliability of J&J’s diversified approach, while those with a keen appetite for growth may consider AbbVie’s potential for higher returns amidst a changing healthcare landscape. As both companies continue to unveil their strategies, regular reassessment will ensure that investors stay ahead in their decisions.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*